Drugs / CCT-102 B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06121063 | Jul 2023 → May 2025 | pregnancy loss, recurrent, 4 | Conceptra Biosciences, LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CCT-102 B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06121063 ↗ |
| Route | Oral | “2 day oral regimen” NCT06121063 ↗ |